Publikationen von Sandra Scheuer
Alle Typen
Zeitschriftenartikel (7)
2019
Zeitschriftenartikel
20 (3), 485 (2019)
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2018
Zeitschriftenartikel
94, S. 134 - 142 (2018)
Childhood abuse and depression in adulthood: The mediating role of allostatic load. PSYCHONEUROENDOCRINOLOGY 2016
Zeitschriftenartikel
73, S. 86 - 95 (2016)
Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. JOURNAL OF PSYCHIATRIC RESEARCH
Zeitschriftenartikel
72, S. 30 - 36 (2016)
FKBP5 polymorphisms moderate the influence of adverse life events on the risk of anxiety and depressive disorders in preschool children. JOURNAL OF PSYCHIATRIC RESEARCH 2015
Zeitschriftenartikel
15, 126 (2015)
Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocol. BMC PSYCHIATRY 2014
Zeitschriftenartikel
19 (5), S. 539 - 561 (2014)
Are there meaningful biomarkers of treatment response for depression? DRUG DISCOVERY TODAY
Zeitschriftenartikel
19 (2), S. 165 - 175 (2014)
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS Konferenzbeitrag (1)
2018
Konferenzbeitrag
83 (9, Suppl.), S74, S. S375 - S376 (2018)
Perspective of Personalized Drug Treatment in Depression. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, 10. Mai 2018 - 12. Mai 2018. BIOLOGICAL PSYCHIATRY Meeting Abstract (1)
2019
Meeting Abstract
29, S. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, 06. Oktober 2018 - 09. Oktober 2018. (2019)
Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY,